Filing Details
- Accession Number:
- 0001070081-19-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-26 17:24:32
- Reporting Period:
- 2019-12-23
- Accepted Time:
- 2019-12-26 17:24:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1707657 | Marcio Souza | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-23 | 6,000 | $48.32 | 53,035 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-23 | 14,814 | $49.14 | 38,221 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-23 | 30,000 | $12.53 | 68,221 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-23 | 8,729 | $48.32 | 59,492 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-23 | 21,271 | $49.14 | 38,221 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-23 | 15,881 | $11.23 | 54,102 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-23 | 8,877 | $48.58 | 45,225 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-23 | 7,004 | $49.32 | 38,221 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-23 | 30,000 | $18.01 | 68,221 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-23 | 11,332 | $48.43 | 56,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-23 | 18,668 | $49.19 | 38,221 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-23 | 6,250 | $12.92 | 11,288 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2019-12-23 | 6,250 | $48.80 | 5,038 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | Disposition | 2019-12-23 | 30,000 | $12.53 | 30,000 | $12.53 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2019-12-23 | 15,881 | $11.23 | 15,881 | $11.23 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2019-12-23 | 30,000 | $18.01 | 30,000 | $18.01 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2019-12-23 | 6,250 | $12.92 | 6,250 | $12.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-05-30 | No | 4 | M | Direct | |
| 7,219 | 2027-01-02 | No | 4 | M | Direct | |
| 45,000 | 2028-01-02 | No | 4 | M | Direct | |
| 3,750 | 2027-05-17 | No | 4 | M | Indirect |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | $33.02 | 2029-01-21 | 112,500 | 112,500 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $33.02 | 2029-01-21 | 25,000 | 25,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $26.42 | 2024-07-31 | 30,000 | 30,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $51.00 | 2025-01-02 | 10,525 | 10,525 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $30.86 | 2026-01-03 | 16,000 | 16,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $12.64 | 2026-11-16 | 2,000 | 2,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $33.02 | 2029-01-21 | 6,825 | 6,825 | Indirect | |
| Common Stock | Stock Option (Right To Buy) | $18.01 | 2028-01-02 | 2,696 | 2,696 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-01-21 | 112,500 | 112,500 | Direct |
| 2029-01-21 | 25,000 | 25,000 | Direct |
| 2024-07-31 | 30,000 | 30,000 | Direct |
| 2025-01-02 | 10,525 | 10,525 | Direct |
| 2026-01-03 | 16,000 | 16,000 | Direct |
| 2026-11-16 | 2,000 | 2,000 | Direct |
| 2029-01-21 | 6,825 | 6,825 | Indirect |
| 2028-01-02 | 2,696 | 2,696 | Indirect |
Footnotes
- The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.75 to $48.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Includes 371 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2019.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.77 to $49.65 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.77 to $48.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.02 to $49.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $49.03 to $49.65 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.82 to $48.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.82 to $49.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The transactions of the Reporting Person's spouse reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on November 19, 2019.
- Currently exerciseable.
- This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
- This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
- This option was granted on May 17, 2017, and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018.
- This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
- This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
- This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- This option was granted on November 17, 2016, and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
Billionaire Hedge Funds
